Author: medweb
-
Standard Treatment May Not Benefit Many Patients With Mild Asthma
Many patients with mild asthma may not benefit from inhaled steroid medications, the current standard treatment, according to a clinical trial published in the New England Journal of Medicine.
-
Exercising to Improve Function in Muscular Dystrophy
Low- and moderate-intensity exercise improved muscle, heart and breathing function in an animal model of Duchenne muscular dystrophy, according to a Northwestern Medicine study.
-
New Director of the Center for Advanced Microscopy
Constadina Arvanitis, PhD, research associate professor of Cell and Developmental Biology, has been named director of the Center for Advanced Microscopy and Nikon Imaging Center.
-
Distinguished Scientist Named Chair of Cell and Developmental Biology
Luisa Iruela-Arispe, PhD, an internationally recognized vascular biologist, has been named the Stephen Walter Ranson Professor and chair of the Department of Cell and Developmental Biology.
-
Uncovering Enzyme’s Dual Role in Cancer Suppression and Growth
A new Northwestern Medicine study has uncovered how a key enzyme in mitochondria can function as both a cancer suppressor and cancer promoter.
-
Protein Quality Control Falters in Neurodegenerative Disease
Northwestern scientists have discovered how certain genetic mutations can weaken protein “quality control,” identifying a pathway that may contribute to neurodegenerative diseases.
-
New Program Connects PhD Students With Clinicians
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
-
Drug Improves Survival in Relapsed Chronic Lymphocytic Leukemia
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
-
Drug Shows Benefit in Metastatic Osteosarcoma
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
-
Only Half of U.S. Kids and Teens Have Ideal Cholesterol Levels
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
